CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
13.48
+0.37 (2.82%)
Oct 29, 2024, 4:00 PM EDT - Market closed

CervoMed Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
10.017.794.096.67
Cash & Short-Term Investments
45.097.794.096.67
Cash Growth
1626.57%90.37%-38.59%-
Other Receivables
-0.92-0.07
Receivables
-0.92-0.07
Prepaid Expenses
2.111.260.060.02
Other Current Assets
0.13--0.05
Total Current Assets
47.339.964.166.82
Other Long-Term Assets
0.060.01--
Total Assets
53.199.974.166.82
Accounts Payable
0.730.660.10.02
Accrued Expenses
0.971.840.590.4
Current Portion of Long-Term Debt
--12.414.11
Other Current Liabilities
0.120.090.050.03
Total Current Liabilities
3.212.613.164.56
Long-Term Debt
---5.92
Total Liabilities
3.212.613.1610.47
Common Stock
0.010.0100
Additional Paid-In Capital
109.2661.8118.9818.52
Retained Earnings
-59.29-54.44-52.27-46.47
Total Common Equity
49.987.38-33.29-27.94
Shareholders' Equity
49.987.38-9-3.66
Total Liabilities & Equity
53.199.974.166.82
Total Debt
--12.4110.03
Net Cash (Debt)
50.97.79-8.32-3.36
Net Cash Per Share
8.322.93-16.06-0.75
Filing Date Shares Outstanding
8.256.174.54.5
Total Common Shares Outstanding
8.255.674.54.5
Working Capital
44.117.37-92.26
Book Value Per Share
6.061.30-7.39-6.21
Tangible Book Value
49.987.38-33.29-27.94
Tangible Book Value Per Share
6.061.30-7.39-6.21
Source: S&P Capital IQ. Standard template. Financial Sources.